Isolation of a novel phage with activity against streptococcus mutans biofilms

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Dalmasso, Marion ^a,b   De Haas, Eric ^a,b   Neve, Horst ^c   Strain, Ronan ^a,b   Cousin, Fabien J ^a,b   Stockdale, Stephen R ^b,d   Ross, R Paul ^a,b   Hill, Colin ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

^d TEAGASC FOOD RESEARCH CENTRE   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

SALIVA SUBSTITUTE;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIOPHAGE; BIOFILM; CONTROLLED STUDY; DENTAL CARIES; GROWTH INHIBITION; HOST RANGE; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; SALIVA ANALYSIS; STREPTOCOCCUS MUTANS; VIRUS GENOME; VIRUS ISOLATION; COMPARATIVE STUDY; MOLECULAR GENETICS; PHYSIOLOGY; SALIVA; STREPTOCOCCUS PHAGE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; VIROLOGY;

BIOFILMS; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR SEQUENCE DATA; SALIVA; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PHAGES;

EID: 84946905495     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138651     Document Type: Article

References (52)

1. Nasidze I, Li J, Quinque D, Tang K, Stoneking M. Global diversity in the human salivary microbiome. Genome Res. 2009; 19(4): 636-43. doi: 10.1101/gr.084616.108 PMID: 19251737.
2. Pride DT, Salzman J, Haynes M, Rohwer F, Davis-Long C, White RA 3rd, et al. Evidence of a robust resident bacteriophage population revealed through analysis of the human salivary virome. ISME journal. 2012; 6(5): 915-26. doi: 10.1038/ismej.2011.169 MEDLINE:PMID: 22158393.
3. Ghannoum MA, Jurevic RJ, Mukherjee PK, Cui F, Sikaroodi M, Naqvi A, et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS pathog. 2010; 6(1): e1000713. doi: 10.1371/journal.ppat.1000713 PMID: 20072605
4. Motegi M, Takagi Y, Yonezawa H, Hanada N, Terajima J, Watanabe H, et al. Assessment of genes associated with Streptococcus mutans biofilm morphology. Appl Environ Microbiol. 2006; 72(9): 6277-87. doi: 10.1128/aem.00614-06 PMID: 16957255
5. Ahn SJ, Ahn SJ, Wen ZT, Brady LJ, Burne RA. Characteristics of biofilm formation by Streptococcus mutans in the presence of saliva. Infect Immun. 2008; 76(9): 4259-68. doi: 10.1128/iai.00422-08 PMID: 18625741.
6. Klein MI, Hwang G, Santos PHS, Campanella OH, Koo H. Streptococcus mutans-derived extracellular matrix in cariogenic oral biofilms. Frontiers in cellular and infection microbiology. 2015; 5. doi: 10.3389/fcimb.2015.00010 PMID: WOS:000349282700001.
7. Banas JA. Virulence properties of Streptococcus mutans. Front Biosci. 2004; 9: 1267-77. PMID: 14977543.
8. Parasion S, Kwiatek M, Gryko R, Mizak L, Malm A. Bacteriophages as an alternative strategy for fighting biofilm development. Polish journal of microbiology / Polskie Towarzystwo Mikrobiologow = The Polish Society of Microbiologists. 2014; 63(2): 137-45. PMID: 25115107.
9. Endersen L, O'Mahoney J, Hill C, Ross RP, McAuliffe O, Coffey A. Phage therapy in the food industry. Annu Rev Food Sci Technol. 2014; 5(1): 327-49. doi: 10.1146/annurev-food-030713-092415
10. Lu TK, Koeris MS. The next generation of bacteriophage therapy. Curr Opin Microbiol. 2011; 14(5): 524-31. doi: 10.1016/j.mib.2011.07.028 PMID: 21868281.
11. Alemayehu D, Casey PG, McAuliffe O, Guinane CM, Martin JG, Shanahan F, et al. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. mBio. 2012; 3(2): e00029-12. doi: 10.1128/mBio.00029-12 PMID: 22396480.
12. Maura D, Galtier M, Le Bouguenec C, Debarbieux L. Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestine. Antimicrob Agents Chemother. 2012; 56 (12): 6235-42. doi: 10.1128/AAC.00602-12 PMID: 23006754
13. Meader E, Mayer MJ, Steverding D, Carding SR, Narbad A. Evaluation of bacteriophage therapy to control Clostridium difficile and toxin production in an in vitro human colon model system. Anaerobe. 2013; 22: 25-30. doi: 10.1016/j.anaerobe.2013.05.001 PMID: 23685029.
14. Chhibber S, Gupta P, Kaur S. Bacteriophage as effective decolonising agent for elimination of MRSA from anterior nares of BALB/c mice. BMC Microbiol. 2014; 14: 212. doi: 10.1186/s12866-014-0212-8 PMID: 25112504.
15. Paisano AF, Spira B, Cai S, Bombana AC. In vitro antimicrobial effect of bacteriophages on human dentin infected with Enterococcus faecalis ATCC 29212. Oral Microbiol Immunol. 2004; 19(5): 327-30. doi: 10.1111/j.1399-302x.2004.00166.x PMID: 15327646.
16. Machuca P, Daille L, Vines E, Berrocal L, Bittner M. Isolation of a novel bacteriophage specific for the periodontal pathogen Fusobacterium nucleatum. Appl Environ Microbiol. 2010; 76(21): 7243-50. doi: 10.1128/aem.01135-10 PMID: 20851973.
17. Phee A, Bondy-Denomy J, Kishen A, Basrani B, Azarpazhooh A, Maxwell K. Efficacy of bacteriophage treatment on Pseudomonas aeruginosa biofilms. J Endod. 2013; 39(3): 364-9. doi: 10.1016/j.joen.2012.10.023 PMID: 23402508.
18. Delisle AL, Guo M, Chalmers NI, Barcak GJ, Rousseau GM, Moineau S. Biology and genome sequence of Streptococcus mutans phage M102AD. Appl Environ Microbiol. 2012; 78(7): 2264-71. doi: 10.1128/aem.07726-11 PMID: 22287009.
19. Van Der Ploeg JR. Genome sequence of Streptococcus mutans bacteriophage M102. FEMS microbiology letters. 2007; 275(1): 130-8. doi: 10.1111/j.1574-6968.2007.00873.x PMID: 17711456
20. Delisle AL, Rostkowski CA. Lytic bacteriophages of Streptococcus mutans. Curr Microbiol. 1993; 27 (3): 163-7. doi: 10.1007/bf01576015 PMID: 23835749.
21. Shibata Y, Ozaki K, Seki M, Kawato T, Tanaka H, Nakano Y, et al. Analysis of loci required for determination of serotype antigenicity in Streptococcus mutans and its clinical utilization. Journal of clinical microbiology. 2003; 41(9): 4107-12. doi: 10.1128/jcm.41.9.4107-4112.2003 PMID: 12958233
22. Casey E, Mahony J, Neve H, Noben J-P, Bello FD, van Sinderen D. Genome and proteome analysis of bacteriophage Ldl1 reveals the existence of a novel phage group infecting Lactobacillus delbrueckii subsp. lactis. Appl Environ Microbiol. 2014; 81(4): 1319-26. doi: 10.1128/aem.03413-14
23. Broussard Gregory W, Oldfield Lauren M, Villanueva Valerie M, Lunt Bryce L, Shine Emilee E, Hatfull Graham F. Integration-Dependent Bacteriophage Immunity Provides Insights into the Evolution of Genetic Switches. Mol Cell. 2013; 49(2): 237-48. doi: http://dx.doi.org/10.1016/j.molcel.2012.11.012 PMID: 23246436
24. Baron F, Cochet M-F, Ablain W, Grosset N, Madec M-N, Gonnet F, et al. Rapid and cost-effective method for micro-organism enumeration based on miniaturization of the conventional plate-counting technique. Lait. 2006; 86(3): 251-7.
25. Boland AB, Buhr K, Giannouli P, van Ruth SM. Influence of gelatin, starch, pectin and artificial saliva on the release of 11 flavour compounds from model gel systems. Food Chem. 2004; 86(3): 401-11. http://dx.doi.org/10.1016/j.foodchem.2003.09.015.
26. Tunney MM, Ramage G, Field TR, Moriarty TF, Storey DG. Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2004; 48(5): 1879-81. PMID: 15105149.
27. Delcher AL, Harmon D, Kasif S, White O, Salzberg SL. Improved microbial gene identification with GLIMMER. Nucleic acids research. 1999; 27(23): 4636-41. PMID: 10556321.
28. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, et al. The RAST Server: rapid annotations using subsystems technology. BMC Genomics. 2008; 9: 75. doi: 10.1186/1471-2164-9-75 PMID: 18261238.
29. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSIBLAST: a new generation of protein database search programs. Nucleic acids research. 1997; 25(17): 3389-402. PMID: 9254694.
30. Jones DT, Taylor WR, Thornton JM. The rapid generation of mutation data matrices from protein sequences. Comput Appl Biosci. 1992; 8(3): 275-82. PMID: 1633570.
31. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013; 30(12): 2725-9. doi: 10.1093/molbev/mst197 PMID: 24132122.
32. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 1985; 39 (4): 783-91. doi: 10.2307/2408678
33. Armau E, Bousque JL, Boue D, Tiraby G. Isolation of lytic bacteriophages for Streptococcus mutans and Streptococcus sobrinus. J Dent Res. 1998; 67: 121.
34. Higuchi M, Rhee GH, Araya S, Higuchi M. Bacteriophage deoxyribonucleic acid-induced mutation of Streptococcus mutans. Infect Immun. 1977; 15(3): 938-44. PMID: 870435.
35. Bachrach G, Leizerovici-Zigmond M, Zlotkin A, Naor R, Steinberg D. Bacteriophage isolation from human saliva. Lett Appl Microbiol. 2003; 36(1): 50-3. PMID: 12485342.
36. Hitch G, Pratten J, Taylor PW. Isolation of bacteriophages from the oral cavity. Lett Appl Microbiol. 2004; 39(2): 215-9. doi: 10.1111/j.1472-765X.2004.01565.x PMID: 15242464
37. Nakano K, Ooshima T. Serotype classification of Streptococcus mutans and its detection outside the oral cavity. Future Microbiol. 2009; 4(7): 891-902. doi: 10.2217/fmb.09.64 PMID: 19722842.
38. Shibata Y, Yamashita Y, van der Ploeg JR. The serotype-specific glucose side chain of rhamnose-glucose polysaccharides is essential for adsorption of bacteriophage M102 to Streptococcus mutans. FEMS microbiology letters. 2009; 294(1): 68-73. doi: 10.1111/j.1574-6968.2009.01546.x PMID: 19493010.
39. van der Ploeg JR. Analysis of CRISPR in Streptococcus mutans suggests frequent occurrence of acquired immunity against infection by M102-like bacteriophages. Microbiol. 2009; 155(Pt 6): 1966-76. doi: 10.1099/mic.0.027508-0 PMID: 19383692.
40. Serbanescu MA, Cordova M, Krastel K, Flick R, Beloglazova N, Latos A, et al. Role of the Streptococcus mutans CRISPR-Cas systems in immunity and cell physiology. J Bacteriol. 2015; 197(4): 749-61. doi: 10.1128/jb.02333-14 PMID: 25488301.
41. Goldfarb T, Sberro H, Weinstock E, Cohen O, Doron S, Charpak-Amikam Y, et al. BREX is a novel phage resistance system widespread in microbial genomes. EMBO J. 2015; 34(2): 169-83. doi: 10.15252/embj.201489455 PMID: 25452498.
42. Mahony J, van Sinderen D. Current taxonomy of phages infecting lactic acid bacteria. Frontiers in microbiology. 2014; 5: 7. doi: 10.3389/fmicb.2014.00007 PMID: 24478767.
43. Wittebole X, De Roock S, Opal SM. A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence. 2014; 4(1): 1-10. http://dx.doi.org/10.4161/viru.25991.
44. O'Flaherty S, Ross RP, Meaney W, Fitzgerald GF, Elbreki MF, Coffey A. Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals. Appl Environ Microbiol. 2005; 71(4): 1836-42. doi: 10.1128/AEM.71.4.1836-1842.2005 PMID: PMC1082512.
45. Ito T, Maeda T, Senpuku H. Roles of salivary components in Streptococcus mutans colonization in a new animal model using NOD/SCID.e2f1-/- mice. PLoS One. 2012; 7(2): e32063. doi: 10.1371/journal.pone.0032063 PMID: 22363797.
46. Decker E-M, Klein C, Schwindt D, von Ohle C. Metabolic activity of Streptococcus mutans biofilms and gene expression during exposure to xylitol and sucrose. In J Oral Sci. 2014; 6(4): 195-204. doi: 10.1038/ijos.2014.38
47. Freires IA, Bueno-Silva B, Galvao LC, Duarte MC, Sartoratto A, Figueira GM, et al. The Effect of essential oils and bioactive fractions on Streptococcus mutans and Candida albicans biofilms: A confocal analysis. Evid Based Complement Alternat Med. 2015; 2015: 871316. doi: 10.1155/2015/871316 PMID: 25821503.
48. O'Connor EB, O'Riordan B, Morgan SM, Whelton H, O'Mullane DM, Ross RP, et al. A lacticin 3147 enriched food ingredient reduces Streptococcus mutans isolated from the human oral cavity in saliva. J Appl Microbiol. 2006; 100(6): 1251-60. doi: 10.1111/j.1365-2672.2006.02856.x PMID: 16696672
49. Wu CC, Lin CT, Wu CY, Peng WS, Lee MJ, Tsai YC. Inhibitory effect of Lactobacillus salivarius on Streptococcus mutans biofilm formation. Molecular oral microbiology. 2014; 30(1): 16-26. doi: 10.1111/omi.12063 PMID: 24961744.
50. Lin X, Chen X, Chen Y, Jiang W, Chen H. The effect of five probiotic lactobacilli strains on the growth and biofilm formation of Streptococcus mutans. Oral Dis. 2015; 21(1): e128-34. doi: 10.1111/odi.12257 PMID: 24806217.
51. Chan BK, Abedon ST, Loc-Carrillo C. Phage cocktails and the future of phage therapy. Future Microbiol. 2013; 8(6): 769-83. doi: 10.2217/fmb.13.47 PMID: 23701332
52. Ly-Chatain MH. The factors affecting effectiveness of treatment in phages therapy. Frontiers in microbiology. 2014; 5: 51. doi: 10.3389/fmicb.2014.00051 PMID: 24600439.